Brokerages expect Colfax Corp (NYSE:CFX) to post $0.62 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have provided estimates for Colfax’s earnings, with estimates ranging from $0.60 to $0.66. Colfax posted earnings per share of $0.45 during the same quarter last year, which indicates a positive year over year growth rate of 37.8%. The company is expected to report its next quarterly earnings results on Tuesday, February 5th.

On average, analysts expect that Colfax will report full year earnings of $2.25 per share for the current year, with EPS estimates ranging from $2.22 to $2.29. For the next fiscal year, analysts anticipate that the company will report earnings of $2.54 per share, with EPS estimates ranging from $2.36 to $2.65. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts that cover Colfax.

Colfax (NYSE:CFX) last announced its quarterly earnings data on Thursday, October 25th. The industrial products company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.52 by $0.02. Colfax had a net margin of 3.03% and a return on equity of 6.97%. The firm had revenue of $875.37 million for the quarter, compared to analyst estimates of $893.38 million.

Several brokerages have recently weighed in on CFX. Zacks Investment Research upgraded shares of Colfax from a “hold” rating to a “buy” rating and set a $38.00 price objective on the stock in a report on Thursday, August 9th. Robert W. Baird reiterated a “buy” rating and set a $38.00 price objective (up previously from $36.00) on shares of Colfax in a report on Monday, August 6th. Barclays upped their target price on shares of Colfax from $29.00 to $30.00 and gave the stock an “underweight” rating in a report on Wednesday, August 8th. Oppenheimer restated a “hold” rating on shares of Colfax in a report on Monday, August 6th. Finally, CIBC upgraded shares of Colfax from a “market perform” rating to an “outperform” rating in a report on Tuesday, September 4th. Four investment analysts have rated the stock with a sell rating, five have assigned a hold rating and eleven have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $34.77.

In other Colfax news, SVP Jason Maclean sold 1,120 shares of the company’s stock in a transaction dated Thursday, November 8th. The shares were sold at an average price of $29.06, for a total value of $32,547.20. Following the completion of the sale, the senior vice president now directly owns 9,716 shares of the company’s stock, valued at approximately $282,346.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 10.20% of the company’s stock.

A number of hedge funds have recently modified their holdings of CFX. Russell Investments Group Ltd. grew its position in Colfax by 210.1% in the 1st quarter. Russell Investments Group Ltd. now owns 62,701 shares of the industrial products company’s stock worth $1,996,000 after purchasing an additional 42,481 shares in the last quarter. Stifel Financial Corp grew its position in Colfax by 64.2% in the 1st quarter. Stifel Financial Corp now owns 10,556 shares of the industrial products company’s stock worth $338,000 after purchasing an additional 4,127 shares in the last quarter. Guggenheim Capital LLC grew its position in Colfax by 6.4% in the 1st quarter. Guggenheim Capital LLC now owns 53,164 shares of the industrial products company’s stock worth $1,696,000 after purchasing an additional 3,216 shares in the last quarter. Millennium Management LLC grew its position in Colfax by 4.7% in the 1st quarter. Millennium Management LLC now owns 265,564 shares of the industrial products company’s stock worth $8,471,000 after purchasing an additional 11,975 shares in the last quarter. Finally, Royal Bank of Canada grew its position in Colfax by 3.1% in the 1st quarter. Royal Bank of Canada now owns 90,748 shares of the industrial products company’s stock worth $2,894,000 after purchasing an additional 2,709 shares in the last quarter. 80.10% of the stock is owned by institutional investors and hedge funds.

Shares of NYSE CFX traded down $0.64 during trading on Monday, hitting $28.09. 1,322,059 shares of the company traded hands, compared to its average volume of 1,107,171. Colfax has a fifty-two week low of $26.25 and a fifty-two week high of $42.08. The firm has a market capitalization of $3.40 billion, a P/E ratio of 16.14, a P/E/G ratio of 0.96 and a beta of 1.56. The company has a current ratio of 1.83, a quick ratio of 1.37 and a debt-to-equity ratio of 0.33.

About Colfax

Colfax Corporation operates as a diversified industrial technology company worldwide. The company operates through Air and Gas Handling, and Fabrication Technology segments. The Air and Gas Handling segment designs, manufactures, and supplies heavy-duty centrifugal and axial fans, rotary heat exchangers, and gas compressors, as well as related products, systems, and services.

Read More: Preferred Stock

Get a free copy of the Zacks research report on Colfax (CFX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Colfax (NYSE:CFX)

Receive News & Ratings for Colfax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colfax and related companies with MarketBeat.com's FREE daily email newsletter.